<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Measures to evaluate standardization of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> therapy after the major revision of guidelines for treatment of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> are not well established </plain></SENT>
<SENT sid="1" pm="."><plain>Our objective was to evaluate the usefulness of <z:hpo ids='HP_0002664'>oncology</z:hpo> market research for measuring the effect of the guidelines on standardization of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> chemotherapy </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The source of data for this analysis was the <z:hpo ids='HP_0002664'>Oncology</z:hpo> Analyzerâ„¢, which provides insight into <z:hpo ids='HP_0002664'>oncology</z:hpo> markets worldwide </plain></SENT>
<SENT sid="3" pm="."><plain>We compared <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> chemotherapy before (July 2008-June 2009) and after the major revision (July 2009-June 2010) of the Japanese guideline in 2009 to determine the effect of the new guidelines on clinical practice </plain></SENT>
<SENT sid="4" pm="."><plain>A total of 1425 patients were enrolled </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: We confirmed that guideline revision had an effect on drug treatment </plain></SENT>
<SENT sid="6" pm="."><plain>Regimens used were in agreement with the recommendations of the new guidelines, except that some characteristics depended on hospital specialization </plain></SENT>
<SENT sid="7" pm="."><plain>A time-course study in 1 year also showed evident change in the use of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> chemotherapy by the third quarter after the revision </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0002664'>Oncology</z:hpo> market research is a useful tool for evaluating standardization of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> chemotherapy </plain></SENT>
<SENT sid="9" pm="."><plain>Furthermore, we expect that this method will contribute to the development of more effective <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> therapies </plain></SENT>
</text></document>